Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Clinical Pharmacology|September 26, 2019
The Case for an Unblinded Modeler in Early Clinical DevelopmentAndreas Krause, Andrea Henrich, Jasper DingemanseCPT: Pharmacometrics & Systems Pharmacology|May 6, 2021
Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y<sub>12</sub> receptor between selatogrel and oral P2Y<sub>12</sub> antagonistsAndrea Henrich, Christian Hove Claussen, Jasper Dingemanse, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 3, 2021
PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QTAndrea Henrich, Pierre-Eric Juif, Jasper Dingemanse, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 6, 2026
Risks encountered when not adjusting for diurnal variation and food effect in QTcF analysis based on phase I dataMaddlie Bardol, Andrea Henrich, Celine Sarr, et al.Clinical Drug Investigation|July 31, 2021
Impact of Daridorexant, a Dual Orexin Receptor Antagonist, on Cardiac Repolarization Following Bedtime Dosing: Results from a Thorough QT Study Using Concentration-QT AnalysisUta Schilling, Andrea Henrich, Clemens Muehlan, et al.Biomolecules|September 28, 2023
Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor AntagonistsChih-Hsuan Hsin, Jasper Dingemanse, Andrea Henrich, et al.Metabolism: Clinical and Experimental|March 23, 2023
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studiesSusanna Bianzano, Andrea Henrich, Lena Herich, et al.The Journal of Pharmacology and Experimental Therapeutics|October 3, 2020
Time-to-Event Analysis of Paclitaxel-Associated Peripheral Neuropathy in Advanced Non-Small-Cell Lung Cancer Highlighting Key Influential Treatment/Patient FactorsFrancis W Ojara, Andrea Henrich, Nicolas Frances, et al.The Journal of Pharmacology and Experimental Therapeutics|June 11, 2017
Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative NeutropeniaAndrea Henrich, Markus Joerger, Stefanie Kraff, et al.CPT: Pharmacometrics & Systems Pharmacology|February 14, 2023
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patientsFrancis Williams Ojara, Andrea Henrich, Nicolas Frances, et al.Pageof 2